Home › Funds › CCM INVESTMENT ADVISERS LLC › ABT

CCM INVESTMENT ADVISERS LLC position in ABT

ABBOTT LABORATORIES · Health Care

CCM INVESTMENT ADVISERS LLC reported holding 113,939 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 0.88% of its reported portfolio and ranking #50 among its reported holdings. CCM INVESTMENT ADVISERS LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)113.94K sh
Reported value held$11.26M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CCM INVESTMENT ADVISERS LLC's ABT position evolved

CCM INVESTMENT ADVISERS LLC first disclosed a stake in ABT in Q3 2023 at 132,996 shares (US$12.9M). The position peaked in Q2 2025 at 110,986 shares, worth US$15.1M. Across 13 filings, CCM INVESTMENT ADVISERS LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 113,939 shares valued at US$11.3M — an increase of 4,951 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 133.00K $12.88M New
Q4 2023 128.22K $14.11M Reduce
Q1 2024 128.52K $14.61M Hold
Q2 2024 123.25K $12.81M Reduce
Q3 2024 118.05K $13.46M Reduce
Q4 2024 115.84K $13.10M Reduce
Q1 2025 111.95K $14.85M Reduce
Q2 2025 110.99K $15.10M Reduce
Q3 2025 103.73K $13.89M Reduce
Q4 2025 102.60K $12.85M Reduce
Q1 2026 101.76K $10.45M Reduce
Q2 2026 108.99K $9.89M Add
Q3 2026 113.94K $11.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has CCM INVESTMENT ADVISERS LLC held ABT?

CCM INVESTMENT ADVISERS LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CCM INVESTMENT ADVISERS LLC's current position in ABT?

As of Q3 2026, CCM INVESTMENT ADVISERS LLC holds 113.94K shares of ABT (ABBOTT LABORATORIES), valued at $11.26M, representing 0.88% of its reported portfolio and ranking #50.

Has CCM INVESTMENT ADVISERS LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), CCM INVESTMENT ADVISERS LLC increased its position in ABT. The position peaked in Q2 2025 at 110.99K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.